Nader Halim, Innervace CEO

Deer­field backs a Penn spin­out aim­ing to shake up Parkin­son's treat­ments us­ing stem cells, brain surgery

Un­like in oth­er neu­rode­gen­er­a­tive dis­eases, such as Alzheimer’s, the pathol­o­gy of Parkin­son’s is rel­a­tive­ly well-un­der­stood. Re­searchers have known for decades that the dis­ease af­fects the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.